Survey of radioiodine therapy safety practices highlights the need for user-friendly recommendations

Thyroid

Volumn 21, Issue 2, 2011, Pages 97-99

  Kloos, Richard T ^a,b  

^a American Thyroid Association   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM; FLUORODEOXYGLUCOSE F 18; IODINE 131; RADIOACTIVE IODINE;

BREAST FEEDING; CONGENITAL HYPOTHYROIDISM; DOSE RESPONSE; DRUG SAFETY; GOITER; HEALTH SURVEY; HUMAN; HYPERTHYROIDISM; INFORMED CONSENT; MEDICAL PRACTICE; NOTE; PREGNANCY TEST; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION SAFETY; THYROID CANCER; THYROID CARCINOMA;

DATA COLLECTION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEALTH PLANNING GUIDELINES; HUMANS; IODINE RADIOISOTOPES; PHYSICIAN'S PRACTICE PATTERNS; RADIOTHERAPY; SOCIETIES, MEDICAL; THYROID DISEASES; UNITED STATES;

EID: 79953245749     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.2102.com     Document Type: Note

References (12)

1. Tran P, Desimone S, Barrett M, Bachrach B 2010 I-131 treatment of Graves' disease in an unsuspected first trimester pregnancy; the potential for adverse effects on the fetus and a review of the current guidelines for pregnancy screening. Int J Pediatr Endocrinol 2010:858359.
2. Nurnberger CE, Lipscomb A 1952 Transmission of radio-iodine (I131) to infants through human maternal milk. JAMA 150:1398-1400.
3. Kloos RT 2009 Protecting thyroid cancer patients from untoward effects of radioactive iodine treatment. Thyroid 19:925-928.
4. Zablotska LB, Ron E, Rozhko AV, Hatch M, Polyanskaya ON, Brenner AV, Lubin J, Romanov GN, McConnell RJ, O'Kane P, Evseenko VV, Drozdovitch VV, Luckyanov N, Minenko VF, Bouville A, Masyakin VB. Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer 2010, E Pub.
5. de Carvalho JW, Sapienza M, Ono C, Watanabe T, Guimaraes MI, Gutterres R, Marechal MH, Buchpiguel C 2009 Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe? Nucl Med Commun 30:533-541.
6. 131I) therapy for thyroid carcinoma. JAMA 283:2272-2274.
7. Marriott CJ, Webber CE, Gulenchyn KY 2007 Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy. Radiat Prot Dosimetry 123:62-67.
8. Pant GS, Sharma SK, Bal CS, Kumar R, Rath GK 2006 Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I. Radiat Prot Dosimetry 118:22-27. (Pubitemid 43786724)
9. Panzegrau B, Gordon L, Goudy GH 2005 Outpatient therapeutic 131I for thyroid cancer. J Nucl Med Technol 33:28-30. (Pubitemid 44783751)
10. Venencia CD, Germanier AG, Bustos SR, Giovannini AA, Wyse EP 2002 Hospital discharge of patients with thyroid carcinoma treated with 131I. J Nucl Med 43:61-65. (Pubitemid 34101189)
11. Greenlee MC, Burmeister LA, Butler R, Edinboro CH, Morrison S, Milas M 2011 Current safety practices relating to I-131 administration for diseases of the thyroid: a survey of physicians and allied practitioners. Thyroid 21: 151-160.
12. Fisher D, Gilley D, Langhorst S, Mattmuller S, Suleiman O, Thomadsen B, Welsh J, Zanzonico P. Advisory Committee on the Medical Use of Isotopes (ACMUI) Patient Release Report. 12-13-2010. www.nrc.gov/about-nrc/regulatory/advisory/ acmui.html (verified December 22, 2010).